Sponsorships and Speaking Engagements | 24 October 2022 | 1:45-3:00 PM (EDT)

AdvaMed MedTech Conference: Artificial Intelligence in Medical Devices: Post Pandemic Implications

On Monday, 24 October, 2022, Washington, D.C. partner Cybil Roehrenbeck will be a panelist speaker during the “Artificial Intelligence in Medical Devices: Post Pandemic Implications” session at the 2022 AdvaMed Tech Conference held in Boston, MA. Cybil and others will discuss how the COVID-19 pandemic has impacted industry and FDA’s approach to using AI in mobile apps, both that are regulated and medical devices and exempt from the definition of device.

This conference will be held in-person from 24-26 October, 2022 in Boston, MA and will feature the world’s top medtech executives will gather for world class plenary speakers, cross cutting educational programming, valuable networking, and business development opportunities. If you would like to register for this conference, please click here.

Back To Listing

Cybil Roehrenbeck

Partner
Washington, D.C.

Brendan O'Leary

Acting Director, Digital Health Center of Excellence, U.S. Food & Drug Administration

}

Zach Rothstein

SVP & Department Deputy, Technology & Regulatory Affairs, AdvaMed

}

Yuri Maricich

Chief Medical Officer and Head of Development, Pear Therapeutics

}

Diane Johnson

Director, Strategic Regulatory, MD&D, Johnson & Johnson

}